COMMUNIQUÉS West-GlobeNewswire

Nemaura Reports Third Quarter 2018 Financial Results
12/02/2019
Loughborough, England – Nemaura Medical, Inc. (NASDAQ: NMRD) nemauramedical.com , a medical technology company focused on the development of SugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose [...]
Anchiano Therapeutics Announces Pricing of $30.5 Million Initial Public Offering
12/02/2019
CAMBRIDGE, Mass., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (Nasdaq and TASE: ANCN) (“Anchiano”) today announced that it has priced its initial public offering of 2,652,174 of its American Depositary [...]
Ventura Cannabis to Acquire Cannabis Dispensaries in Cathedral City, California, and Portland, Oregon With Combined Annual Revenues of $2,500,000
12/02/2019
Secures Former Morgan Stanley, Merrill Lynch Executive as Senior Advisor NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ALL FIGURES IN CANADIAN DOLLARS UNLESS [...]
AXIM® Biotechnologies Announces Significant Initial Purchase Order for Nutraceutical Product With Leading Direct Selling Company
12/02/2019
NEW YORK, Feb. 12, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (“AXIM ® Biotech” or “AXIM”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today announced that the company has received [...]
Researchers at Queen’s University Belfast have Developed a Vaginal Ring Capable of Providing Sustained Delivery of OB-002 (5P12-RANTES) for HIV Prevention
12/02/2019
OTTAWA, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced that researchers at the School of Pharmacy, Queen’s University Belfast, have published [...]
Fortress Biotech Completes Final Stage Closing of the Sale of its Remaining Shares of National Holdings Corporation
12/02/2019
NEW YORK, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential clinical-stage [...]
Veritas Pharma Enters into agreement to acquire Commercial Hemp and Cannabis Processing Facility
12/02/2019
VANCOUVER, British Columbia, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it has entered into an agreement [...]
SELLAS Life Sciences Provides Galinpepimut-S and Nelipepimut-S Program Update
12/02/2019
Dr. Richard Maziarz and Dr. Roisin O'Cearbhaill Named Co-Principal Investigators for Galinpepimut-S (GPS) – Pembrolizumab Phase 1/2 Basket Trial Immune Response Data from the Phase 2b Nelipepimut-S (NPS) plus [...]
Teladoc Health to Announce Fourth Quarter and Full-Year 2018 Financial Results
12/02/2019
PURCHASE, NY, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Teladoc Health , Inc. (NYSE: TDOC), the global leader in virtual care, announced today that it will release fourth quarter and full-year 2018 results on Wednesday, [...]
Ritter Pharmaceuticals to Host Expert Call with Dr. William Chey on February 20, 2019
12/02/2019
Leading Gastrointestinal Disease Expert to Address Unmet Medical Need in Lactose Intolerance and the Potential of Phase 3 Drug Candidate RP-G28 LOS ANGELES, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc [...]
Vericel to Report Fourth-Quarter 2018 Financial Results on February 26, 2019
12/02/2019
CAMBRIDGE, Mass., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the following webcast and [...]
Genocea Announces Private Placement Financing of Up to $39 Million
12/02/2019
CAMBRIDGE, Mass., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced that it has entered into a [...]
Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2018 Financial Results and Corporate Update
12/02/2019
NOVATO, Calif., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases [...]
Coloplast continues to expand its SenSura® Mio ostomy range with the new, innovative, first-of-its-kind SenSura® Mio Convex Flip ostomy product.
12/02/2019
Designed specifically for the outward body shapes – and the first of its kind in the ostomy market – the new SenSura® Mio Convex Flip is now available in the United States. All bodies are different, and it is a [...]
Medexus Lists October 2018 Unsecured Convertible Debentures on the TSX Venture Exchange
12/02/2019
MONTREAL, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) (the “Company”) (TSXV: MDP, OTCQB: PDDPF) today announced that the 6.0% unsecured convertible debentures of the Company [...]
WW Schedules Fourth Quarter and Full Year 2018 Earnings Conference Call
12/02/2019
NEW YORK, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Weight Watchers International, Inc. (NASDAQ: WTW) (“WW”) will release its results for the fourth quarter and full year 2018 after market close on Tuesday, February 26, 2019. [...]
IRIDEX Announces Resolution of its Dispute with Quantel Medical
12/02/2019
MOUNTAIN VIEW, Calif., Feb. 12, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced that it has resolved its differences with Quantel Medical, S.A., Quantel USA, Inc., and Quantel, S.A. ( [...]
Progressive Care Inc. Announces CEO, Shital Mars as Keynote Speaker at Cold Chain Global Forum in Toronto, Canada
12/02/2019
MIAMI, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that CEO, Shital Mars will be the keynote speaker at Cold Chain [...]
BioSig Technologies Inc. Issues 2019 Shareholder Letter
12/02/2019
Company provides updates on recent developments and highlights plans for future growth Santa Monica, CA, Feb. 12, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a [...]

Pages